ZBH vs. LMAT

Last updated Jun 4, 2026

ZBH (Zimmer Biomet Holdings, Inc.) and LMAT (LeMaitre Vascular, Inc.) are both stocks. Both are in the Healthcare sector — ZBH in Medical Devices, LMAT in Medical Instruments & Supplies. Over the past 10 years, ZBH returned -2.46%/yr vs 21.12%/yr for LMAT. At a 0.24 correlation, their price movements are largely independent.

Performance

ZBH vs. LMAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ZBH achieves a -5.24% return, which is significantly lower than LMAT's 13.54% return. Over the past 10 years, ZBH has underperformed LMAT with an annualized return of -2.46%, while LMAT has yielded a comparatively higher 21.12% annualized return.

ZBH

• 1D: 1.47%
• 1M: 2.79%
• YTD: -5.24%
• 6M: -8.23%
• 1Y: -6.51%
• 3Y*: -12.39%
• 5Y*: -10.52%
• 10Y*: -2.46%

LMAT

• 1D: 0.02%
• 1M: -17.63%
• YTD: 13.54%
• 6M: 8.43%
• 1Y: 11.61%
• 3Y*: 13.29%
• 5Y*: 13.41%
• 10Y*: 21.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ZBH vs. LMAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ZBH Zimmer Biomet Holdings, Inc.	-5.24%	-14.03%	-12.46%	-3.81%	4.24%	-17.02%	3.77%	45.37%	-13.30%	17.86%
LMAT LeMaitre Vascular, Inc.	13.54%	-10.95%	63.63%	24.60%	-7.40%	25.10%	14.09%	53.77%	-25.13%	26.58%

Correlation

The correlation between ZBH and LMAT is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.37
Correlation (3Y) Calculated over the trailing 3-year period	0.35
Correlation (5Y) Calculated over the trailing 5-year period	0.40
Correlation (10Y) Calculated over the trailing 10-year period	0.37
Correlation (All Time) Calculated using the full available price history since Oct 20, 2006	0.24

The correlation between ZBH and LMAT shifts across timeframes, from 0.24 (all time) to 0.40 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ZBH : $16.64B LMAT : $2.11B
EPS ZBH : $3.85 LMAT : $2.68
PE Ratio ZBH : 22.07 LMAT : 34.25
PEG Ratio ZBH : 0.32 LMAT : 1.47
PS Ratio ZBH : 2.00 LMAT : 8.34
PB Ratio ZBH : 1.13 LMAT : 5.19
Total Revenue (TTM) ZBH : $8.41B LMAT : $256.28M
Gross Profit (TTM) ZBH : $5.89B LMAT : $185.52M
EBITDA (TTM) ZBH : $2.21B LMAT : $90.48M

Return for Risk

ZBH vs. LMAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH

ZBH Risk / Return Rank: 30
ZBH Sharpe Ratio Rank: 32
ZBH Sortino Ratio Rank: 28
ZBH Omega Ratio Rank: 28
ZBH Calmar Ratio Rank: 32
ZBH Martin Ratio Rank: 31

LMAT

LMAT Risk / Return Rank: 51
LMAT Sharpe Ratio Rank: 52
LMAT Sortino Ratio Rank: 51
LMAT Omega Ratio Rank: 49
LMAT Calmar Ratio Rank: 52
LMAT Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZBH vs. LMAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ZBH	LMAT	Difference
Sharpe ratio Return per unit of total volatility	-0.22	0.32	-0.54
Sortino ratio Return per unit of downside risk	-0.08	0.89	-0.97
Omega ratio Gain probability vs. loss probability	0.99	1.10	-0.12
Calmar ratio Return relative to maximum drawdown	-0.26	0.53	-0.79
Martin ratio Return relative to average drawdown	-0.51	1.09	-1.61
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ZBH vs. LMAT - Sharpe Ratio Comparison

The current ZBH Sharpe Ratio is -0.22, which is lower than the LMAT Sharpe Ratio of 0.32. The chart below compares the historical Sharpe Ratios of ZBH and LMAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ZBH	LMAT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	0.32	-0.54
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.40	0.37	-0.77
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	0.51	-0.60
Sharpe Ratio (All Time) Calculated using the full available price history	0.18	0.34	-0.16

Drawdowns

ZBH vs. LMAT - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum LMAT drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for ZBH and LMAT.

Drawdown Indicators

	ZBH	LMAT	Difference
Max Drawdown Largest peak-to-trough decline	-65.03%	-75.69%	+10.66%
Max Drawdown (1Y) Largest decline over 1 year	-25.54%	-21.93%	-3.61%
Max Drawdown (3Y) Largest decline over 3 years	-43.94%	-33.32%	-10.62%
Max Drawdown (5Y) Largest decline over 5 years	-48.62%	-37.93%	-10.69%
Max Drawdown (10Y) Largest decline over 10 years	-52.14%	-47.65%	-4.49%
Current Drawdown Current decline from peak	-48.89%	-21.74%	-27.15%
Average Drawdown Average peak-to-trough decline	-20.05%	-18.95%	-1.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.72%	10.65%	+2.07%

Volatility

ZBH vs. LMAT - Volatility Comparison

The current volatility for Zimmer Biomet Holdings, Inc. (ZBH) is 7.44%, while LeMaitre Vascular, Inc. (LMAT) has a volatility of 10.03%. This indicates that ZBH experiences smaller price fluctuations and is considered to be less risky than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ZBH	LMAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.44%	10.03%	-2.59%
Volatility (6M) Calculated over the trailing 6-month period	20.09%	29.18%	-9.09%
Volatility (1Y) Calculated over the trailing 1-year period	30.38%	36.54%	-6.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.60%	36.40%	-9.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.43%	41.46%	-13.03%

Dividends

ZBH vs. LMAT - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 1.13%, more than LMAT's 0.98% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LMAT LeMaitre Vascular, Inc.	0.98%	1.23%	0.69%	0.99%	1.09%	0.88%	0.94%	0.95%	1.18%	0.69%	0.71%	0.93%
ZBH Zimmer Biomet Holdings, Inc.	1.13%	1.07%	0.91%	0.79%	0.75%	0.76%	0.62%	0.64%	0.93%	0.80%	0.93%	0.86%

Financials

ZBH vs. LMAT - Profitability Comparison

The chart below illustrates the profitability comparison between Zimmer Biomet Holdings, Inc. and LeMaitre Vascular, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.

Frequently Asked Questions

Can I hold both ZBH and LMAT in my portfolio?

ZBH and LMAT have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ZBH or LMAT?

LMAT has higher volatility (10.03%) compared to ZBH (7.44%). In terms of maximum drawdown, ZBH dropped -65.03% vs LMAT's -75.69%.

Which has better risk-adjusted returns?

LMAT currently has the higher Sharpe Ratio (0.32 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.